期刊文献+

CXCR 4CD44 CD133表达在舌鳞状细胞癌患者生存分析中的价值 被引量:5

Survival analysis of tongue squamous cell carcinoma with CXCR4, CD44 and CD133 expression
下载PDF
导出
摘要 目的:探讨影响舌鳞状细胞癌患者术后生存的相关因素。方法:回顾性分析经病理确诊并行手术治疗的44例舌鳞癌患者临床资料,采用免疫组织化学方法检测不同病理分级舌鳞癌患者癌组织中CXCR4、CD44、CD133的表达情况。将可能影响患者术后生存的指标进行Kaplan-Meier检验后,采用Cox比例风险回归模型进行多因素分析。结果:本研究44例舌鳞癌标本中,高分化29例,中、低分化15例;Ⅰ期11例,Ⅱ期12例,Ⅲ期8例,Ⅳ期13例。各病理分级病例CXCR4、CD44、CD133阳阳性率分别是79.54%(35/44)、77.27%(34/44)和75.00%(33/44)。CXCR4、CD44、CD133在舌鳞癌各病理分级组在之间表达强度差异均有统计学意义(P<0.05),且CXCR4、CD44、CD133分别与转移、复发也成正相关。Cox模型多因素分析提示:CXCR4表达情况、临床分期、颈部转移为本组舌鳞癌患者预后独立的影响因素及死亡的危险因素。结论:CXCR4、CD44、CD133的表达与舌鳞癌的恶性程度存在相关性,CXCR4表达情况、临床分期、颈部转移为术后评价舌鳞癌患者生存的重要指标。 Objective: This study aimed to analyze the correlation of the expression of CXCR4, CD44, and CD133 proteins with the clinicopathological characteristics of patients to identify the factors affecting the post-operation survival rate of tongue squamous cell carcinomas (TSCCs). Methods: Clinical data of 44 patients with TSCCs were collected and retrospectively analyzed. The diagno- ses of all cases were pathologically confirmed. CXCR4, CD44, and CD 133 expression in 44 TSCCs patients with different pathological grades was examined immunohistochemically. Survival curves were processed in accordance with the Kaplan-Meier method. The Cox regression model was used for the multivariate analysis of relevant clinical and survival data. Results: Among the 44 examined TSCCs patients, 29 cases were well differentiated and 15 were moderately or poor differentiated; 11 cases were stage I, 12 were stage II, 8 were stage III, and 13 were stage IV. Positive staining of CXCR4, CD44, and CD133 was found in all cases with different degrees. Ac- cording to the pathological tumor grade, the positive rates of CXCR4, CD44, and CD133 expression were 79.54% (35/44 cases),77.27% (34/44 cases), and 75.00% (33/44 cases), respectively. Expression of CXCR4, CD44, and CD 133 significantly differed between different histological grades (P〈0.05). Correlation analysis indicated that the expression of CXCR4, CD44, and CD133 was positively correlated with the metastasis, recurrence of TSCCs. COX multivariate analysis indicated that CXCR4 expression, clinical stage, and neck metastasis were independent prognostic predictors of TSCCs patients and risk factors of death. Conclusion: CXCR4, CD44, and CD133 may be correlated with the malignancy of TSCCs. CXCR4 expression, clinical stage, cervical lymph node metastasis were the correlated prognosis factors of TSCC patients after operation.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2013年第14期832-837,共6页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金(编号:30060082) 教育部“春晖计划”科研启动基金(编号:教外司留[2003]593-7) 广西自然科学基金重点项目(编号:2010GXNSFD013047) 广西科学基金(编号:桂科回0836013,2013GXNSFAA019231) 广西卫生厅重点科研项目(编号:重200006,重200927) 广西教育厅立项项目(编号:2006-64)~~
关键词 舌鳞状细胞癌 CXCR4 CD44 CD133 生存分析 tongue squamous cell carcinoma, CXCR4, CD44, CD133, survival analysis
  • 相关文献

参考文献18

  • 1Price KA, Cohen EE. Current treatment options for metastatic head and neck cancer[J]. Curt Treat Options Oncol, 2012, 13(1):35-46.
  • 2Brerman S, Corry J, Kleid S, et al. Prospective trial to evaluate staged neck dissection or elective neck radiotherapy in patients with CT-staged T1-2 NO squamous cell carcinoma of the oral tongue [J]. Head Neck, 2010, 32(2):191-198.
  • 3Popovtzer A, Shpitzer T, Bahar G, et al. Squamous cell carcinoma of the oral tongue in young patients[J]. Laryngoscope, 2004, 144(5): 915-917.
  • 4Zhou L, Wei X, Cheng L, et al. CD133, one of the markers of cancer stem cells in Hep-2 cell line[J]. Laryngoscope, 2007, 117(3):455-460.
  • 5Pardal R, Clarke MF, Morrison SJ.Applying the principles of stem-cell biology to cancer[J]. Nature Rev Cancer, 2003, 3 (12):895-902.
  • 6Woo SU, BaeJW, Kim CH, et al. A significant correlation between nuclear CXCR4 expression and axillary lymph node metastasis in hormonal receptor negative breast cancer[J]. Ann Surg Oncol, 2008, 15(1):281-285.
  • 7Ou DL, Chen CL, Lin SB, et al. Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with me-tastasis and radiotherapy[J].J Pathol, 2006, 210(3):363-373.
  • 8Delilbasi CB, Okura M, Iida S, et al. Investigation of CXCR4 in squamous cell carcinoma of the tongue[J]. Oral Oncol, 2004, 40(2): 154-157.
  • 9孙传政,陈福进,曾宗渊,邓莅霏,杨安奎,陈艳峰.92例晚期舌鳞状细胞癌的治疗及预后分析[J].中华口腔医学杂志,2006,41(11):650-653. 被引量:13
  • 10华辉,曾宗渊,许光普.临床Ⅰ、Ⅱ期舌体鳞癌患者预后的多因素分析[J].癌症,2003,22(2):210-213. 被引量:3

二级参考文献34

  • 1马向涛,余力伟,张在兴,王杉,杜如昱,崔志荣.趋化因子受体CXCR4/CXCL12信号转导通路在结直肠癌肝转移中的作用[J].世界华人消化杂志,2006,14(16):1566-1570. 被引量:10
  • 2Kenji Koishi,Reigetsu Yoshikawa,Tohru Tsujimura,Tomoko Hashimoto-Tamaoki,Syoudou Kojima,Hidenori Yanagi,Takehira Yamamura,Yoshinori Fujiwara.Persistent CXCR4 expression after preoperative chemoradiotherapy predicts early recurrence and poor prognosis in esophageal cancer[J].World Journal of Gastroenterology,2006,12(47):7585-7590. 被引量:10
  • 3杨朝晖,黄洪章,潘朝斌,陈伟良,李劲松,赵小朋.舌癌术后远期生存质量影响因素的评价[J].中国口腔颌面外科杂志,2007,5(2):104-106. 被引量:12
  • 4杨果凡 陈宝驹 等.前臂皮瓣游离移植术(附56例报告)[J].中华医学杂志,1981,6(3):139-139.
  • 5[1]Haas I, Hauser U, Ganzer U. The dilemma of follow-up in head and neck cancer patients [J]. European Archives of Oto-RhinoLaryngology,2001,258(4): 177-183.
  • 6[3]Sato F, Shimada Y, Li Z, et al. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma[J].Br J Surg,2001,88(3):426-432.
  • 7[4]Kraus DH, Vastola P, Huvos AG, et al. Surgical management of squamous cell carcinoma of the base of the tongue[J]. Am J Surg,1993,166:384-386.
  • 8[5]Nakamur T, Ide H, Eguchi R,et al. Clinical implications of lymph node micrometastasis in patients with histologically node-negative(pNO) esophageal carcinoma[J]. J Surg Oncol,2002,79(4):224-229.
  • 9[7]Noguchi S, Aiham T,Motomura K,et al. Detection of breast cancer micrometastasis in axillary lymph nodes by means of reverse transcription-polymerase chain reaction comparison between MUC1mRNA and keratin 19 mRNA amplification[J]. Am J Pathol,1996,148(2):649-656.
  • 10[8]Sato F, Shimada Y, Li Z, et al . Lymph node micrometastases and prognosis in patients with oesophageal squamous cell carcinoma[J].Br J Surg,2001,88:426-432.

共引文献42

同被引文献30

  • 1刘健,浦剑虹,葛自力.CD44V6和MMP-9在口腔鳞癌组织中的表达及其相关性研究[J].临床口腔医学杂志,2005,21(6):333-335. 被引量:4
  • 2Hashitani S, Urade M, Zushi Y, et al. Establishment of nude mouse transplantable model of a human adenoid cystic carcinoma of the oral floor showing metastasis to the lymph node and lung[J]. Oncol Rep, 2007, 17( 1 ):67 -72.
  • 3Liang Z, Brooks J, Willard M, et al. CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway [ J ]. Biochem Biophys Res Commun, 2007, 359(3) :716 -722.
  • 4Ao M, Franco OE, Park D, et al. Cross-talk between para- erine-acting cytokine and ehemokine pathways promotes ma- lignancy in benign human prostatic epithelium [ J ]. Cancer Res, 2007, 67(9):4244-4253.
  • 5Aatayama A, Ogino T, Bandoh N, et al. Expression of CX- CR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma [ J ]. Clin Cancer Res,2005, 11 ( 8 ) : 2937 - 2946.
  • 6Zagzag D, Lukyanov Y, Lan L, et al. Hypoxia-inducible factor land VEGF upregulate CXCR4 in glioblastoma: Im- plications for angiogenesis and glioma cell invasion [ J ]. Lab Invest, 2006, 86(12) :1221 - 1232.
  • 7Burger JA, Kipps TJ. CXCR4: A key receptor in the crosstalk between tumor cells and their microenvironment [J]. Blood, 2006, 107(5) :1761 - 1767.
  • 8Darash-Yahana M, Pikarsky E, Abramoviteh R, et al. Role of high expression levels of CXCR4 in tumor growth, vascu-larization, and metastasis [ J ]. FASEB J, 2004, 18 ( 11 ) : 1240 - 1242.
  • 9Almofti A, Uehida D, Begum NM, et al. The clinicopatho- logical significance of the expression of CXCR4 protein in o- ral squamous cell carcinoma [ J]. Int J Oncol, 2004, 25 (1) :65 -71.
  • 10唐毕锋(综述),马立业(审校).肿瘤干细胞及其与CD133的关系[J].国际肿瘤学杂志,2008,35(5):326-329. 被引量:1

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部